205 related articles for article (PubMed ID: 1495997)
1. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
Citro G; Perrotti D; Cucco C; D'Agnano I; Sacchi A; Zupi G; Calabretta B
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7031-5. PubMed ID: 1495997
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B
Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
[TBL] [Abstract][Full Text] [Related]
3. Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides.
Ho PT; Ishiguro K; Wickstrom E; Sartorelli AC
Antisense Res Dev; 1991; 1(4):329-42. PubMed ID: 1821654
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
Raschellà G; Negroni A; Skorski T; Pucci S; Nieborowska-Skorska M; Romeo A; Calabretta B
Cancer Res; 1992 Aug; 52(15):4221-6. PubMed ID: 1638535
[TBL] [Abstract][Full Text] [Related]
5. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
Anfossi G; Gewirtz AM; Calabretta B
Proc Natl Acad Sci U S A; 1989 May; 86(9):3379-83. PubMed ID: 2541445
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
[TBL] [Abstract][Full Text] [Related]
8. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging.
Calabretta B; Sims RB; Valtieri M; Caracciolo D; Szczylik C; Venturelli D; Ratajczak M; Beran M; Gewirtz AM
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2351-5. PubMed ID: 2006173
[TBL] [Abstract][Full Text] [Related]
9. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
Ginobbi P; Geiser TA; Ombres D; Citro G
Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
[TBL] [Abstract][Full Text] [Related]
10. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
Ratajczak MZ; Kant JA; Luger SM; Hijiya N; Zhang J; Zon G; Gewirtz AM
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11823-7. PubMed ID: 1281545
[TBL] [Abstract][Full Text] [Related]
11. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G
Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated oligodeoxynucleotides delivery by estradiol and folic acid polylysine conjugates.
Citro G; Ginobbi P; Szczylik C
Cytotechnology; 1993; 11 Suppl 1():S30-4. PubMed ID: 7764059
[TBL] [Abstract][Full Text] [Related]
13. A DNA uptake-stimulating protein increases the antiproliferative effect of c-myb antisense oligonucleotide on leukemic cells.
Tóth G; Schlammadinger J; Aradi J; Antal-Szalmás P; Sipka S; Balázs M; Kovács P; Fehér Z; Falus A
Cell Biol Int; 2004; 28(11):817-23. PubMed ID: 15563404
[TBL] [Abstract][Full Text] [Related]
14. The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells.
Reiss K; Porcu P; Sell C; Pietrzkowski Z; Baserga R
Oncogene; 1992 Nov; 7(11):2243-8. PubMed ID: 1359494
[TBL] [Abstract][Full Text] [Related]
15. Chemical modification of ligands for cell receptors to introduce foreign compounds into the cells.
Citro G; Ginobbi P; Candiloro A; Meloni A; Sarti P; Milani A [corrected to Meloni A]
Dis Colon Rectum; 1994 Feb; 37(2 Suppl):S127-32. PubMed ID: 8313784
[TBL] [Abstract][Full Text] [Related]
16. G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb.
Gewirtz AM; Anfossi G; Venturelli D; Valpreda S; Sims R; Calabretta B
Science; 1989 Jul; 245(4914):180-3. PubMed ID: 2665077
[TBL] [Abstract][Full Text] [Related]
17. Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients.
Venturelli D; Mariano MT; Szczylik C; Valtieri M; Lange B; Crist W; Link M; Calabretta B
Cancer Res; 1990 Nov; 50(22):7371-5. PubMed ID: 2224864
[TBL] [Abstract][Full Text] [Related]
18. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro.
Simons M; Rosenberg RD
Circ Res; 1992 Apr; 70(4):835-43. PubMed ID: 1551207
[TBL] [Abstract][Full Text] [Related]
19. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
Cucco C; Calabretta B
Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
